The Medical Center of Aurora serves Aurora, Colorado and the eastern Denver-Aurora Metropolitan Area with four separate campuses providing a wide range of health care services. It was founded in 1974; it now employs more than 1,200 people and is part of HealthONE, the largest health care system in the metro area.

There are 346 beds in The Medical Center of Aurora.

During the past decade, The Medical Center of Aurora conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 104 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 53 clinical trials were completed. i.e. 139.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Medical Center of Aurora" #1 sponsor was "National Cancer Institute (NCI)" with 111 trials, followed by "SWOG Cancer Research Network" with 26 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Eastern Cooperative Oncology Group" with 15 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Medical Center of Aurora" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "Canadian Cancer Trials Group" with 8 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "The Medical Center of Aurora" are "Recurrent Breast Carcinoma" (10 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Melanoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (7 trials). Many other conditions were trialed in "The Medical Center of Aurora" in a lesser frequency.

Most popular intervention types in "The Medical Center of Aurora" are "Drug" (175 trials), "Other" (133 trials), "Biological" (99 trials), "Procedure" (46 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (49 trials), "Paclitaxel" (29 trials), "Questionnaire Administration" (26 trials) and "Bevacizumab" (23 trials). Other intervention names were less common.

The vast majority of trials in "The Medical Center of Aurora" are 180 trials for "All" genders, 33 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "The Medical Center of Aurora". undefined are not yet recruiting, 40 are recruiting, 92 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in The Medical Center of Aurora, 3 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in The Medical Center of Aurora, 3 "Phase 1" clinical trials were conducted, 84 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".